These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Clinical characteristics and outcomes of chédiak-Higashi syndrome: a nationwide survey of Japan. Nagai K; Ochi F; Terui K; Maeda M; Ohga S; Kanegane H; Kitoh T; Kogawa K; Suzuki N; Ohta S; Ishida Y; Okamura T; Wakiguchi H; Yasukawa M; Ishii E Pediatr Blood Cancer; 2013 Oct; 60(10):1582-6. PubMed ID: 23804531 [TBL] [Abstract][Full Text] [Related]
3. Patients with early relapse of primary hemophagocytic syndromes or with persistent CNS involvement may benefit from immediate hematopoietic stem cell transplantation. Sparber-Sauer M; Hönig M; Schulz AS; zur Stadt U; Schütz C; Debatin KM; Friedrich W Bone Marrow Transplant; 2009 Sep; 44(6):333-8. PubMed ID: 19252534 [TBL] [Abstract][Full Text] [Related]
4. Treatment of the X-linked lymphoproliferative, Griscelli and Chédiak-Higashi syndromes by HLH directed therapy. Trottestam H; Beutel K; Meeths M; Carlsen N; Heilmann C; Pasić S; Webb D; Hasle H; Henter JI Pediatr Blood Cancer; 2009 Feb; 52(2):268-72. PubMed ID: 18937330 [TBL] [Abstract][Full Text] [Related]
5. Fludarabine-based reduced-intensity conditioning regimen for hematopoietic stem cell transplantation in primary hemophagocytic lymphohistiocytosis. Hamidieh AA; Pourpak Z; Hashemi S; Yari K; Fazlollahi MR; Movahedi M; Behfar M; Moin M; Ghavamzadeh A Eur J Haematol; 2014 Apr; 92(4):331-6. PubMed ID: 24330187 [TBL] [Abstract][Full Text] [Related]
6. Hematopoietic stem cell transplantation for children with primary immunodeficiency diseases: single center experience in Jordan. Amayiri N; Al-Zaben A; Ghatasheh L; Frangoul H; Hussein AA Pediatr Transplant; 2013 Jun; 17(4):394-402. PubMed ID: 23692601 [TBL] [Abstract][Full Text] [Related]
7. Incidence and Outcomes of Central Nervous System Hemophagocytic Lymphohistiocytosis Relapse after Reduced-Intensity Conditioning Hematopoietic Stem Cell Transplantation. Lounder DT; Khandelwal P; Chandra S; Jordan MB; Kumar AR; Grimley MS; Davies SM; Bleesing JJ; Marsh RA Biol Blood Marrow Transplant; 2017 May; 23(5):857-860. PubMed ID: 28219834 [TBL] [Abstract][Full Text] [Related]
8. Chediak-Higashi syndrome: Lessons from a single-centre case series. Carneiro IM; Rodrigues A; Pinho L; de Jesus Nunes-Santos C; de Barros Dorna M; Moschione Castro APB; Pastorino AC Allergol Immunopathol (Madr); 2019; 47(6):598-603. PubMed ID: 31477396 [TBL] [Abstract][Full Text] [Related]
10. Split chimerism after allogeneic bone marrow transplantation in Chediak-Higashi syndrome. Yamazaki S; Takahashi H; Fujii H; Miyamae T; Mori M; Fujioka K; Funabiki T; Yokota S; Arai N; Ikuta K Bone Marrow Transplant; 2003 Jan; 31(2):137-40. PubMed ID: 12621497 [TBL] [Abstract][Full Text] [Related]
11. Towards the targeted management of Chediak-Higashi syndrome. Lozano ML; Rivera J; Sánchez-Guiu I; Vicente V Orphanet J Rare Dis; 2014 Aug; 9():132. PubMed ID: 25129365 [TBL] [Abstract][Full Text] [Related]
12. Cognitive and psychosocial function post hematopoietic stem cell transplantation in children with hemophagocytic lymphohistiocytosis. Jackson J; Titman P; Butler S; Bond K; Rao A; Veys P; Chiesa R; Leiper A; Riley L; Gilmour K; Amrolia P; Rao K J Allergy Clin Immunol; 2013 Oct; 132(4):889-95.e1-3. PubMed ID: 23987797 [TBL] [Abstract][Full Text] [Related]
13. In patients with Chediak-Higashi syndrome undergoing allogeneic SCT, does adding etoposide to the conditioning regimen improve the outcome? Ayas M; Al-Ghonaium A Bone Marrow Transplant; 2007 Sep; 40(6):603. PubMed ID: 17637689 [No Abstract] [Full Text] [Related]
14. Risk for complications in patients with hemophagocytic lymphohistiocytosis who undergo hematopoietic stem cell transplantation: myeloablative versus reduced-intensity conditioning regimens. Schechter T; Naqvi A; Weitzman S Expert Rev Clin Immunol; 2014 Aug; 10(8):1101-6. PubMed ID: 24871821 [TBL] [Abstract][Full Text] [Related]
15. Living-Donor Lung Transplantation After Bone Marrow Transplantation for Chediak-Higashi Syndrome. Yamada T; Chen-Yoshikawa TF; Oh S; Ito-Taniguchi R; Gochi F; Sato M; Aoyama A; Date H Ann Thorac Surg; 2017 Mar; 103(3):e281-e283. PubMed ID: 28219570 [TBL] [Abstract][Full Text] [Related]
16. Failure of sustained engraftment after non-myeloablative conditioning with low-dose TBI and T cell-reduced allogeneic peripheral stem cell transplantation. Kreiter S; Winkelmann N; Schneider PM; Schuler M; Fischer T; Ullmann AJ; Huber C; Derigs HG; Kolbe K Bone Marrow Transplant; 2001 Jul; 28(2):157-61. PubMed ID: 11509933 [TBL] [Abstract][Full Text] [Related]
18. Haploidentical Stem Cell Transplant With Post-transplant Cyclophosphamide for Chediak-Higashi Syndrome: A Very Rare Case Report. Sachdev M; Bansal M; Chakraborty S; Hamal S; Bhargava R; Dua V J Pediatr Hematol Oncol; 2021 Oct; 43(7):e1030-e1032. PubMed ID: 33093354 [TBL] [Abstract][Full Text] [Related]